The novel type I serine–threonine kinase receptor Alk8 binds TGF-β in the presence of TGF-βRII
- 24 May 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 293 (5) , 1556-1565
- https://doi.org/10.1016/s0006-291x(02)00424-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The TGFβ Receptor Activation ProcessMolecular Cell, 2001
- The type I serine/threonine kinase receptor Alk8/Lost-a-fin is required for Bmp2b/7 signal transduction during dorsoventral patterning of the zebrafish embryoDevelopment, 2001
- Role of Transforming Growth Factor-beta Signaling in CancerJNCI Journal of the National Cancer Institute, 2000
- Assignment of Transforming Growth Factor β1 and β3 and a Third New Ligand to the Type I Receptor ALK-1Published by Elsevier ,1999
- Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family ReceptorsPublished by Elsevier ,1999
- Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2Journal of Biological Chemistry, 1998
- Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible EnhancerJournal of Biological Chemistry, 1998
- Characterization of Functional Domains within Smad4/DPC4Journal of Biological Chemistry, 1997
- Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptorsCell, 1993
- Determination of Type I Receptor Specificity by the Type II Receptors for TGF-β or ActivinScience, 1993